Targeting cellular senescence as a novel treatment for osteoarthritis

Area of Science:

• Gerontology and Regenerative Medicine
• Cell Biology and Molecular Medicine
• Rheumatology and Orthopedics

Background:

• Cellular senescence plays roles in normal development and wound healing.
• Senescence is implicated in aging-related diseases, notably osteoarthritis (OA).
• The senescence-associated secretory phenotype (SASP) contributes to disease pathogenesis.

Purpose of the Study:

• To review current therapeutic strategies targeting cellular senescence and SASP for OA.
• To highlight the expanding field of senotherapeutics and identify new mechanistic targets.
• To underscore the need for further research into senotherapeutics for OA.

Main Methods:

• Review of pre-clinical and clinical studies on senotherapeutics.
• Analysis of mechanistic targets of cell senescence and SASP.
• Examination of challenges in therapeutic targeting of senescence.

Main Results:

• Targeting senescent cells and SASP is a developing treatment strategy for OA.
• New mechanistic targets for senescence and SASP are continually being identified.
• Current senotherapeutics show promise but lack demonstrated long-term efficacy.

Conclusions:

• Therapeutic targeting of senescence presents a promising avenue for OA treatment.
• Diverse senescent cell phenotypes pose challenges for effective therapeutic development.
• Further studies are crucial to develop and validate senotherapeutics as disease-modifying OA treatments.